⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BNTX News
BioNTech SE American Depositary Share
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union
businesswire.com
BNTX
PFE
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union
globenewswire.com
PFE
BNTX
Correction: Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
globenewswire.com
JNJ
BNTX
GMAB
IMUX
INO
PDSB
AZN
GSK
MRK
BIIB
EXEL
REGN
CUE
IOBT
RAPT
PRE
European Patent Office Confirms Patent Protection for SOT201, SOTIO's Clinical-Stage Immunocytokine Showing Promising Anti-Tumor Activity
globenewswire.com
BNTX
BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026
globenewswire.com
BNTX
NCLA Urges Supreme Court to Hear Vaccine Mandate Case that Clearly Misreads Precedent
globenewswire.com
BNTX
Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders
globenewswire.com
ABUS
ROIV
PFE
BNTX
MRNA
Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
globenewswire.com
JNJ
BNTX
CUE
GMAB
IMPP
INO
AZN
GSK
MRK
BMY
EXEL
REGN
PDSB
IOVA
RPTX
Explosive Growth Predicted in the In Silico Protein Design Market with Focus on AI and Automation
globenewswire.com
BNTX
Global TROP-2 Targeted Therapy Market Set to Reach USD 3.29 Billion by 2031 with an 8.6% CAGR
globenewswire.com
GILD
AZN
PFE
MRK
BMY
BIIB
BNTX